source
- BIO urges US to create White House biotech office and streamline trials to stay ahead of ChinaThe Biotechnology Innovation Organization (BIO) released a seven-point "Bio Advance" plan aimed at strengthening the United States' biotech sector. The proposals call for easing the start-up of cli…
- Altimmune to discuss Phase 3 design for alcohol use disorder drug with FDAAltimmune is preparing to meet the FDA in December to discuss the design of a pivotal Phase 3 trial for its glucagon/GLP-1 dual receptor agonist pemvidutide. The Phase 2 RECLAIM study enrolled abo…